Evonik and Vland Biotech form JV in Qingdao on animal gut health products

http://www.vlandbiochem.com/article-5545-10977.html

On March 14, 2024, Evonik Vland Biotech (Shandong) Co., Ltd. was put into operation in Qingdao, China. The joint venture of Evonik China Co., Ltd. and Shandong Vland Biotech Co., Ltd. aims to develop and expand gut health solutions products including probiotics for farm animals in China. Evonik holds the majority with a share of 55 %.

Head of Evonik’s life science division Nutrition & Care, the Animal Nutrition business line is Johann-Caspar Gammelin.

The joint venture is headquartered in Vland Biotech Innovation Park in Qingdao, China, and Vland’s production facilities in Binzhou, Shandong Province, China., will be utilized.

“Benefiting from the strong innovation capabilities, applied technology expertise and excellent reputation of the two parent companies, we will deliver innovative products and solutions to the market, and create more value for our customers,” says Dr. Wang Xu, general manager of Evonik Vland Biotech (Shandong) Co., Ltd.

more insights

A lipid-rich baker’s yeast mutant provides high yields of palmitoleic acid

http://english.cas.cn/newsroom/research_news/life/202508/t20250801_1048868.shtml

https://biotechnologyforbiofuels.biomedcentral.com/articles/10.1186/s13068-025-02677-8

A team at CAS Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT) has developed a lipid-rich mutant strain of Saccharomyces cerevisiae for microbial production of palmitoleic acid— a rare omega-7 fatty acid with proven anti-inflammatory and metabolic benefits.

The team used a combined mutagenesis approach—employing zeocin, an antibiotic-based mutagen, and Atmospheric and Room Temperature Plasma (ARTP)—to create a diverse library of yeast mutants. They then deployed FlowRACS, a Raman flow cytometry system, to select live yeast cells with elevated lipid levels by analyzing their intrinsic single-cell Raman spectra, eliminating the need for chemical stains or genetic reporters.

This method identified the mutant strain MU2R48, which achieved a lipid content of 40.26%—a 30.85% increase over its parental strain SC018—while maintaining similar biomass production.

Photo: Raman flow cytometry efficiently identifies lipid-rich Saccharomyces cerevisiae  mutants from a Zeocin–ARTP-induced library. (Image by QIBEBT)

Sept. 13 – 16, 2025: 2nd International Conference on Green Carbon in Qingdao and online

Registration is open: https://conf.sciencemate.com/ICGC2025

ICGC aims to provide an interdisciplinary academic exchange platform and academic community for scientific and technological innovation in the area of CO₂ emission reduction and sustainable development. The conference will focus on carbon resources, carbon conversion technologies, carbon life cycle management, and breakthrough developments in green carbon science.

Qingdao Institute of Bioenergy and Bioprocess Technology, CAS/Shandong Energy Institute (QIBEBT/SEI) is a research institute that is active in science and technology developments of bioenergy, fossil energy, hydrogen energy, energy storage devices, and energy informatics, see http://english.qibebt.cas.cn

A hydrogen-powered tugboat in Qingdao port

https://j.people.com.cn/n3/2025/0627/c95952-20333735.html

The tugboat was designed and built by Shandong Port Qingdao Port Group Co., Ltd. and is equipped with a hybrid system of “hydrogen fuel cells + liquid-cooled lithium batteries” to achieve zero carbon dioxide emissions. It can sail for more than 12 hours at a speed of 9 knots and has a towing force of 82 tons. With technologies such as fully automatic smart on-shore charging, it has become the country’s largest port tugboat in terms of horsepower and lithium battery capacity.

Back to …

青岛 Qingdao
a hub for S&T